Aspira Womens Health

Yahoo Finance • last year

Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

Aspira Women's Health Inc. Aspira management will be available for meetings in San Francisco (January 8-10, 2024) AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bi... Full story

Yahoo Finance • last year

Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)

AUSTIN, Texas, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynec... Full story

Yahoo Finance • last year

Aspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)

CMS approves OvaWatchSM 2024 price at $897 per test AUSTIN, Texas, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercia... Full story

Yahoo Finance • last year

Aspira Women’s Health Reports Third Quarter 2023 Financial Results

Product revenue increased 9% to $2.2 million for the quarter, and 19% to $7.0 million year to date OvaSuite sales volume increased 5% to 5,783 units for the quarter, and 16% to 18,331 units year to date Third quarter cash utilization of... Full story

Yahoo Finance • last year

Aspira Women’s Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch

The proposed rule would allow for OvaWatchSM to be reimbursed at the same rate as Ova1® at $897 per test and will become final following a brief public comment period AUSTIN, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Healt... Full story

Yahoo Finance • last year

Aspira Women’s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research

AUSTIN, Texas, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynec... Full story

Yahoo Finance • last year

Aspira Women’s Health Establishes a New Clinical Advisory Board

AUSTIN, Texas, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynec... Full story

Yahoo Finance • last year

New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT

NEW YORK, Oct. 20, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a national TV show, announces episode 524th airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT. New to The Street's 524th TV episode li... Full story

Yahoo Finance • last year

Aspira Women’s Health to Present at the BioVenture Nexus Conference

AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gyne... Full story

Yahoo Finance • last year

Aspira Women’s Health Regains Nasdaq Compliance

AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gyne... Full story

Yahoo Finance • last year

Aspira Women’s Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference

AUSTIN, Texas, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development of women’s health diagnostic tools for gynecologic diseases, today... Full story

Yahoo Finance • last year

Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations

AUSTIN, Texas, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc.(“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development of women’s health diagnostic tools for gynecologic diseases, today... Full story

Yahoo Finance • last year

Aspira Women’s Health® Reports Second Quarter 2023 Financial Results

Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022. OvaSuiteSM volume of 6,289 units, an increase of 16% year-over-year Achieved cash used in operations of $3.4 million,... Full story

Yahoo Finance • last year

Aspira Women’s Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD

AUSTIN, Texas, June 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, tod... Full story

Yahoo Finance • 2 years ago

New to The Street Announces Five Corporate Interviews on its 478th Show, Airing on the Fox Business Network, Tonight, Monday, June 12, 2023, at 10:30 PM PT

NEW YORK, June 12, 2023 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street, a nationally syndicated TV show, announces episode 478 airing on the Fox Business Network, tonight Monday, June 12, 2023,at 10:30 PM PT. New to The Street’s 478t... Full story

Yahoo Finance • 2 years ago

Aspira Women’s Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference

AUSTIN, Texas, May 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it wou... Full story

Yahoo Finance • 2 years ago

Aspira Women’s Health Names Torsten Hombeck as Chief Financial Officer

AUSTIN, Texas, May 16, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has... Full story

Yahoo Finance • 2 years ago

Aspira Women’s Health to Host Investor Day on OvaWatch(SM) and EndoCheck™ Market Opportunities on May 23, 2023

AUSTIN, Texas, May 15, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it wil... Full story

Yahoo Finance • 2 years ago

Aspira Women’s Health launches its New to The Street Media Series on May 8, 2023, World Ovarian Cancer Day

NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- FMW Media Works' New to The Street will feature and broadcast Aspira Women's Health, Inc. (NASDAQ: AWH) (AWH) on its nationwide television media platforms. Jane King, New to The Street’s TV Host... Full story

Yahoo Finance • 2 years ago

Aspira Women’s Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test

AUSTIN, Texas, May 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today announced it has signed an exclusive licensing agreement with t... Full story